China Vs Cancer: An Infographic Snapshot
Executive Summary
Cancer cases are rising in China, with larger increases for certain types including thyroid and pancreatic. To combat the rising tide, the government will implement zero tariffs on imported anticancer drugs from May.
You may also be interested in...
China Zero Tariffs For Cancer Drugs Precede High-Stakes Trade Talks
China is opening up its domestic pharma market with an import duty exemption on 28 drugs including anticancers, effective May. The duty cuts came ahead of the latest trade talks between the US and China, though Chinese officials have underscored that countries like India could also stand to gain.
Zero Tariff On Anticancer Drugs To China, Will MNCs Sing Hymn?
Commonly-prescribed medicines, especially imported anticancer drugs, will potentially see zero tariffs in China, although this may be a symbolic sign rather than a substantive move to improve market access for highly-priced products, some say.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues.